Predict your next investment

Venture Capital
morgenthaler.com

See what CB Insights has to offer

Investments

499

Portfolio Exits

97

About Morgenthaler Ventures

Morgenthaler is a leading U.S. venture-capital firm with offices in Menlo Park, California; Boston, Massachusetts; Princeton, New Jersey; Boulder, Colorado and Cleveland, Ohio.

Morgenthaler Ventures Headquarter Location

2710 Sand Hill Road 100

Menlo Park, California, 94025,

United States

(650) 388-7600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Morgenthaler Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Morgenthaler Ventures in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

113 items

Latest Morgenthaler Ventures News

Nuvaira Raises $79M in Financing

Feb 11, 2019

Nuvaira , a Minneapolis, Minn.-based developer of novel therapeutic medical devices to treat obstructive lung diseases, closed a $79m equity financing. The round was led by U.S. Venture Partners, with participation from Endeavour Vision, Qiming Venture Partners, Lightstone Ventures and Richard King Mellon Foundation and existing investors Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, Versant Ventures, Vertex Venture Holdings, and Windham Venture Partners. The company intends to use the funds to support the pivotal AIRFLOW-3 clinical trial for FDA approval and to implement a targeted clinical development strategy in key European markets. Led by Dennis Wahr, M.D., Chief Executive Officer, Nuvaira provides the lung denervation system that addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma in a procedure called Targeted Lung Denervation (TLD). Its proprietary technology has demonstrated safety and feasibility in three clinical studies: IPS-I/II, AIRFLOW-1, and, most recently, the AIRFLOW-2 sham controlled randomized clinical trial, which was presented at the European Respiratory Society conference in September 2018. The Nuvaira Lung Denervation System is CE Mark approved, and is under clinical investigation and is not commercially available in the USA. Nuvaira and dNerva are registered trademarks of Nuvaira, Inc. The company also announced that Lisa Rogan has joined its executive team as senior vice president of market development, bringing with her over 20 years of medical device industry expertise in commercializing disruptive diagnostic and therapeutic technologies, including ten years of experience with interventional pulmonary devices targeting treatment of severe COPD. FinSMEs 11/02/2019

Morgenthaler Ventures Investments

499 Investments

Morgenthaler Ventures has made 499 investments. Their latest investment was in Relievant Medsystems as part of their Series G on October 10, 2020.

CBI Logo

Morgenthaler Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/29/2020

Series G

Relievant Medsystems

$70M

No

7

2/14/2019

Series E

Nuvaira

$79M

No

4

12/28/2018

Series F

NuoDB

$30.55M

No

1

10/11/2018

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

11/1/2017

Series E - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2020

2/14/2019

12/28/2018

10/11/2018

11/1/2017

Round

Series G

Series E

Series F

Series D - II

Series E - II

Company

Relievant Medsystems

Nuvaira

NuoDB

Subscribe to see more

Subscribe to see more

Amount

$70M

$79M

$30.55M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

4

1

10

10

Morgenthaler Ventures Portfolio Exits

97 Portfolio Exits

Morgenthaler Ventures has 97 portfolio exits. Their latest portfolio exit was Doximity on June 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/24/2021

IPO

$99M

Public

6

11/25/2020

Acquired

$99M

7

1/22/2020

Acquired

$99M

1

11/18/2019

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

11/15/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2021

11/25/2020

1/22/2020

11/18/2019

11/15/2019

Exit

IPO

Acquired

Acquired

Acq - Fin

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

6

7

1

10

10

Morgenthaler Ventures Acquisitions

12 Acquisitions

Morgenthaler Ventures acquired 12 companies. Their latest acquisition was Arisdyne Systems on June 18, 2008.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/18/2008

Debt

$99M

$10.85M

Acquired

7/9/2007

$99M

Acquired

9/19/2006

Debt

$99M

$7.5M

Acquired

7/15/2006

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

0

5/19/2006

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/18/2008

7/9/2007

9/19/2006

7/15/2006

5/19/2006

Investment Stage

Debt

Debt

Series D

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$10.85M

$7.5M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

0

0

Morgenthaler Ventures Team

10 Team Members

Morgenthaler Ventures has 10 team members, including current Founding Partner, David Morgenthaler.

Name

Work History

Title

Status

David Morgenthaler

Founding Partner

Current

David Morgenthaler

Founding Partner

Current

Robert C. Bellas

General Partner

Current

Jason Lettmann

Promedior, Split Rock Partners, Accenture, and University of Iowa

General Partner

Current

Rebecca Lynn

General Partner

Current

Name

David Morgenthaler

David Morgenthaler

Robert C. Bellas

Jason Lettmann

Rebecca Lynn

Work History

Promedior, Split Rock Partners, Accenture, and University of Iowa

Title

Founding Partner

Founding Partner

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.